BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 17502396)

  • 1. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
    Chinchilla M; Pasetti MF; Medina-Moreno S; Wang JY; Gomez-Duarte OG; Stout R; Levine MM; Galen JE
    Infect Immun; 2007 Aug; 75(8):3769-79. PubMed ID: 17502396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
    Galen JE; Zhao L; Chinchilla M; Wang JY; Pasetti MF; Green J; Levine MM
    Infect Immun; 2004 Dec; 72(12):7096-106. PubMed ID: 15557633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-Directed AAV8 Booster Vaccine Expressing
    Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
    Front Immunol; 2021; 12():612910. PubMed ID: 34248928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL.
    Ruiz-Pérez F; León-Kempis R; Santiago-Machuca A; Ortega-Pierres G; Barry E; Levine M; González-Bonilla C
    Infect Immun; 2002 Jul; 70(7):3611-20. PubMed ID: 12065502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
    Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA
    PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.
    Gómez-Duarte OG; Pasetti MF; Santiago A; Sztein MB; Hoffman SL; Levine MM
    Infect Immun; 2001 Feb; 69(2):1192-8. PubMed ID: 11160021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
    Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
    Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
    Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
    Zhang M; Kaneko I; Tsao T; Mitchell R; Nardin EH; Iwanaga S; Yuda M; Tsuji M
    Malar J; 2016 Apr; 15():201. PubMed ID: 27068454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice.
    Arama C; Assefaw-Redda Y; Rodriguez A; Fernández C; Corradin G; Kaufmann SH; Reece ST; Troye-Blomberg M
    Vaccine; 2012 Jun; 30(27):4040-5. PubMed ID: 22521849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences.
    Hayashi CTH; Cao Y; Zavala F; Simonyan H; Young CN; Kumar N
    Vaccine; 2023 Nov; 41(46):6824-6833. PubMed ID: 37827967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol.
    Haddad D; Liljeqvist S; Ståhl S; Hansson M; Perlmann P; Ahlborg N; Berzins K
    Scand J Immunol; 1999 May; 49(5):506-14. PubMed ID: 10320644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost.
    Ramirez K; Capozzo AV; Lloyd SA; Sztein MB; Nataro JP; Pasetti MF
    J Immunol; 2009 Jan; 182(2):1211-22. PubMed ID: 19124765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.
    Gonzalez C; Hone D; Noriega FR; Tacket CO; Davis JR; Losonsky G; Nataro JP; Hoffman S; Malik A; Nardin E; Sztein MB; Heppner DG; Fouts TR; Isibasi A; Levine MM
    J Infect Dis; 1994 Apr; 169(4):927-31. PubMed ID: 8133113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
    Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.
    Wang R; Epstein J; Charoenvit Y; Baraceros FM; Rahardjo N; Gay T; Banania JG; Chattopadhyay R; de la Vega P; Richie TL; Tornieporth N; Doolan DL; Kester KE; Heppner DG; Norman J; Carucci DJ; Cohen JD; Hoffman SL
    J Immunol; 2004 May; 172(9):5561-9. PubMed ID: 15100299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
    PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
    Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
    Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy.
    Vindurampulle CJ; Cuberos LF; Barry EM; Pasetti MF; Levine MM
    Vaccine; 2004 Sep; 22(27-28):3744-50. PubMed ID: 15315855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein.
    Iyori M; Nakaya H; Inagaki K; Pichyangkul S; Yamamoto DS; Kawasaki M; Kwak K; Mizukoshi M; Goto Y; Matsuoka H; Matsumoto M; Yoshida S
    PLoS One; 2013; 8(8):e70819. PubMed ID: 23951015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.